Carimune®

Carimune® NF is indicated for the maintenance treatment of patients with primary immunodeficiencies (PID, e.g., common variable immunodeficiency, X-linked agammaglobulinemia, severe combined immunodeficiency.
Carimune® NF is preferable to intramuscular Immune Globulin (Human) preparations in treating patients who require an immediate and large increase in the intravascular immunoglobulin level, in patients with limited muscle mass, and in patients with bleeding tendencies for whom intramuscular injections are contraindicated. The infusions must be repeated at regular intervals.
For indications, dosing and other information, please refer to the prescribing information.

Carimune® NF ‐ CSL Behring

Size:
6 gram vial
NDC #:
44206-0417-06
Download:
PI
Size:
12 gram vial
NDC #:
44206-0418-12
Download:
PI